Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with failure to rescue after major hepatectomy for perihilar cholangiocarcinoma: A 15-year single-center experience.

Surgery·2022
Same author

Minimally invasive liver surgery: the Charité experience.

Turkish journal of surgery·2022
Same author

Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach.

Cancers·2022
Same author

Hyperkalemia Following Parathyroidectomy in Patients with Renal Hyperparathyroidism-New Thresholds for Urgent Perioperative Dialysis.

Journal of clinical medicine·2022
Same author

Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients.

Vaccines·2021
Same author

Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure?

Cancers·2021

Related Experiment Video

Updated: May 13, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.3K

[Cholangiocarcinomas].

Wenzel Schöning1, Philipp K Haber1, Johann Pratschke2

  • 1Chirurgische Klinik, Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland.

Chirurgie (Heidelberg, Germany)
|December 10, 2024
PubMed
Summary

Cholangiocarcinoma (CCA) encompasses diverse bile duct cancers with varied characteristics. This review covers recent advancements in surgical techniques and systemic treatments to improve oncological outcomes.

Keywords:
Biliary tract cancerHepatic neoplasmsHepatopancreatobiliary surgeryMinimally invasive surgeryRobotic surgery

More Related Videos

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

179
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

96

Related Experiment Videos

Last Updated: May 13, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.3K
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

179
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

96

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Innovation

Background:

  • Cholangiocarcinoma (CCA) comprises a heterogeneous group of malignant tumors arising from the bile ducts.
  • Significant variations exist in etiology, pathogenesis, clinical presentation, diagnostics, and treatment strategies among intrahepatic, perihilar, and distal CCA subtypes.
  • Understanding this heterogeneity is crucial for effective disease management.

Purpose of the Study:

  • To present current developments in the field of cholangiocarcinoma research and clinical practice.
  • To highlight recent innovations in surgical procedures for CCA.
  • To discuss the application of novel systemic treatments aimed at enhancing the radicality of surgical cancer removal.

Main Methods:

  • This study is a review article synthesizing current knowledge on cholangiocarcinoma.
  • It focuses on recent advancements reported in the literature regarding surgical and systemic therapies.
  • Information is gathered on innovations in clinical routine and emerging treatment modalities.

Main Results:

  • Surgical innovations are being integrated into the clinical management of CCA.
  • New systemic therapies are being explored to improve the effectiveness of surgery.
  • The review consolidates recent progress in addressing the heterogeneity of CCA.

Conclusions:

  • Advances in surgical techniques and systemic treatments offer improved prospects for cholangiocarcinoma patients.
  • Addressing the heterogeneity of CCA through tailored approaches is key.
  • Continued research into innovative therapies is essential for augmenting oncological outcomes in CCA.